Abbvie Inc (NYSE:ABBV)

141.96
Delayed Data
As of Oct 04
 -0.03 / -0.02%
Today’s Change
106.86
Today|||52-Week Range
175.91
+4.84%
Year-to-Date
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Oct 04 / Zacks.com - Paid Partner Content
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
Oct 02 / MotleyFool.com - Paid Partner Content
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks
Oct 04 / Zacks.com - Paid Partner Content
Here's Why This Dividend King Is a Buy
Oct 01 / MotleyFool.com - Paid Partner Content
PARK NATIONAL CORP /OH/ Buys 4, Sells 1 in 3rd Quarter
Oct 03 / GuruFocus News - Paid Partner Content
3 Safe Stocks You'll Want to Have Exposure to in 2022
Sep 30 / StockNews.com - Paid Partner Content
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Oct 03 / Zacks.com - Paid Partner Content
Where Will AbbVie Be in 3 Years?
Sep 30 / MotleyFool.com - Paid Partner Content
Bear Market Bargains: 3 Dividend Stocks to Buy Now
Oct 03 / MotleyFool.com - Paid Partner Content
Where to Invest $10,000 Right Now
Sep 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close141.99
Today’s open139.48
Day’s range137.82 - 142.71
Volume15
Average volume (3 months)5,819,411
Market cap$237.3B
Data as of 4:00pm ET, 10/04/2022

Growth & Valuation

Earnings growth (last year)+137.07%
Earnings growth (this year)+9.13%
Earnings growth (next 5 years)-2.00%
Revenue growth (last year)+22.69%
P/E ratio20.1
Price/Sales4.28
Price/Book15.40

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.32+0.72%
MRKMerck+0.01+0.01%
LLYEli Lilly and Co+0.20+0.06%
NVONovo Nordisk-0.01-0.01%
Data as of 4:00pm ET, 10/04/2022

Financials

Next reporting dateNovember 4, 2022
EPS forecast (this quarter)$3.60
Annual revenue (last year)$56.2B
Annual profit (last year)$11.5B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts